Department of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
Graduate Program in Genetics and Genomics, Division of Graduate Medical Sciences, Boston University School of Medicine, Boston, MA 02118, USA.
Int J Mol Sci. 2020 Dec 31;22(1):387. doi: 10.3390/ijms22010387.
For decades, the aryl hydrocarbon receptor (AHR) was studied for its role in environmental chemical toxicity i.e., as a quirk of nature and a mediator of unintended consequences of human pollution. During that period, it was not certain that the AHR had a "normal" physiological function. However, the ongoing accumulation of data from an ever-expanding variety of studies on cancer, cancer immunity, autoimmunity, organ development, and other areas bears witness to a staggering array of AHR-controlled normal and pathological activities. The objective of this review is to discuss how the AHR has gone from a likely contributor to genotoxic environmental carcinogen-induced cancer to a master regulator of malignant cell progression and cancer aggression. Particular focus is placed on the association between AHR activity and poor cancer outcomes, feedback loops that control chronic AHR activity in cancer, and the role of chronically active AHR in driving cancer cell invasion, migration, cancer stem cell characteristics, and survival.
数十年来,芳香烃受体(AHR)一直因其在环境化学毒性方面的作用而受到研究,即作为自然界的一种怪癖和人类污染的意外后果的中介。在这期间,AHR 是否具有“正常”的生理功能尚不确定。然而,越来越多的来自癌症、癌症免疫、自身免疫、器官发育和其他领域的研究数据不断积累,见证了 AHR 控制的正常和病理活动的惊人多样性。本综述的目的是讨论 AHR 如何从可能导致遗传毒性环境致癌物诱导癌症的因素转变为恶性细胞进展和癌症侵袭的主要调节因子。特别关注的是 AHR 活性与癌症不良预后之间的关联、控制癌症中慢性 AHR 活性的反馈回路,以及慢性激活的 AHR 在驱动癌细胞侵袭、迁移、癌症干细胞特征和存活中的作用。